Tag: Viemed Healthcare
Viemed’s growth engine gains momentum
August 21, 2026Theresa Flaherty
LAFAYETTE, La. – Viemed posted new highs in the second quarter with growth across its core ventilation business and continued expansion in its sleep resupply and maternal health lines, say company execs.
“At the midpoint of the year, Viemed is larger and more diversified than ever,” said CEO Casy Hoyt on a recent call to discuss the company’s earnings. “We entered the second half with multiple sources of growth, a larger patient base and the financial capacity to...
Viemed’s growth engines fire as vent, sleep patient counts climb
August 4, 2026HME News Staff
LAFAYETTE, La. – Viemed Healthcare reported net revenues of $78.1 million for the second quarter, a 23.9% increase compared to the prior-year quarter and a company record.
The company also reported:
Net income was $2.8 million, or $0.07 per diluted share
Adjusted EBITDA was $13.7 million, a 4% decrease. The prior year period included a $1.0 million non-recurring gain on disposal of property and equipment related to the ventilator return program, which benefited net income and...
Viemed juggles diversified portfolio
May 8, 2026Theresa Flaherty
LAFAYETTE, La. – Viemed is hitting an inflection point in its ventilator business under new Medicare rules, with stronger compliance and accelerating referrals offset by higher patient turnover. Growth in sleep and maternal health has added to the company’s momentum, says CEO Casey Hoyt.
Ventilator business evolving
A new national coverage determination (NCD) for home mechanical ventilation (HMV), implemented Oct. 22, has several new requirements, including compliance monitoring...
Viemed’s efforts pay off, with revenues increasing 28%
May 6, 2026HME News Staff
LAFAYETTE, La. – Viemed Healthcare reported net revenues of $75.4 million for the first quarter ended March 31, 2026, an increase of $16.3 million, or 28%, over the comparable quarter in 2025.
Net income attributable to Viemed totaled $2.6 million, or $0.06 per diluted share. Adjusted EBITDA was $14.3 million, a 12% increase.
“The first quarter showed clearly that the work we have put into diversifying and scaling this platform is paying off,” said Casey Hoyt, CEO. “Sleep...
Viemed revenues reflect organic growth, Lehan’s acquisition
March 5, 2026HME News Staff
LAFAYETTE, La. – Viemed Healthcare reported revenues of $76.2 million for the fourth quarter ended Dec. 31, 2025, an increase of 26% over the same quarter in 2024.
Total revenues for full-year 2025 were $270.3 million, an increase of $46 million or 21% over full-year 2024, reflecting continued strong organic growth complemented by revenue contributions from the company’s 2025 acquisition of Lehan's Medical Equipment.
Net income attributable to Viemed totaled $5.6 million for...
Viemed’s diversification efforts pay off
November 12, 2025Theresa Flaherty
LAFAYETTE, La. – Viemed Healthcare’s sleep business accelerated “meaningfully” in the third quarter of 2025 with a 96% increase in new patient starts year over year. The business will remain a key driver in the company’s push for diversified growth, says CEO Casey Hoyt.
Sleep surges during quarter
Resupply grew 51% year-over-year and 33% sequentially, surpassing its PAP rental base for the first time, said Hoyt on a recent call to discuss the company’s...
Viemed sees boost from Lehan’s in Q3
November 6, 2025HME News Staff
LAFAYETTE, La. – Viemed Healthcare reported revenue of $71.9 million for the third quarter 2025, a 24% increase compared to the previous quarter in 2024. Adjusted EBITDA totaled $16.1 million, a 15.5% increase.
During the quarter:
Viemed repurchased and cancelled 1,706,380 common shares under its share repurchase program at a cost of $11.4 million, representing an average buyback price of $6.68 per share; and
Closed on its acquisition...
Viemed completes share repurchase
September 29, 2025HME News Staff
LAFAYETTE, La. - Viemed Healthcare has completed all repurchases authorized under its previously announced share repurchase program. "Completing this share repurchase program highlights both our confidence in Viemed's long-term outlook and our ongoing commitment to enhancing shareholder value,” said Casey Hoyt, Viemed's CEO. “With our strong balance sheet and ample liquidity driven by increasing free cash flow, we remain well positioned to continue investing in growth opportunities...
Viemed reports strong sleep therapy growth, eyes resupply boom ahead
August 8, 2025Theresa Flaherty
LAFAYETTE, La. – Viemed reported strong growth for its second quarter, with the fastest growth in its sleep division, CEO Casey Hoyt said on a recent earnings call.
During the quarter, the company’s sleep therapy patient census was up 15% sequentially and 51% year-over-year. New patient setups were up 72% year-over-year.
“We're focused on aggressively maintaining this growth trend with eight new sleep areas launched since the beginning of the year,”...
Viemed sees ongoing organic growth
August 7, 2025HME News Staff
LAFAYETTE, La. – Viemed Healthcare remained “on track” during the second quarter of 2025, reporting revenue of $63.1 million, an increase of 14.7% over the same period in 2024.
Adjusted EBITDA for the quarter totaled $14.3 million, an 11.5% increase.
"The solid execution of our vent and sleep businesses - together with continued leveraging of expenses - produced second quarter results that met our expectations and kept us on track for our organic growth...